MOCHIDA PHARMACEUTICAL CO revenue for the last year amounted to 103.26 B JPY, the most of which — 97.34 B JPY — came from its highest performing source at the moment, Drug-related, the year earlier bringing 104.45 B JPY. The greatest contribution to the revenue figure was made by Japan — last year it brought MOCHIDA PHARMACEUTICAL CO 103.26 B JPY, and the year before that — 110.18 B JPY.